Plant Breeding: Antisense ODN Inhibition in in vitro spike cultures as a powerful Diagnostic Tool in Studies on Cereal Grain Development

2007 ◽  
pp. 179-190 ◽  
Author(s):  
Christer Jansson ◽  
Chuanxin Sun ◽  
Seedhabadee Ganeshan ◽  
Ravindra N. Chibbar
Author(s):  
L. Marras ◽  
R. Fontana ◽  
M. C. Gambino ◽  
M. Greco ◽  
M. Materazzi ◽  
...  

2021 ◽  
pp. medethics-2020-106940
Author(s):  
Emily C Lisi

Madison Kilbride recently argued that insurance (eg, Centers for Medicare & Medicaid Services (CMS)) should cover in vitro fertilisation with preimplantation genetic testing (IVF-PGT) services for couples at high risk of having a child affected with a genetic condition. She argues that IVF-PGT meets CMS’s definition of ‘medically necessary care’, where such care includes ‘services or supplies needed to diagnose or treat an illness, injury, condition, disease or its symptoms’. Kilbride argues that IVF-PGT satisfies this definition in two ways: as a diagnostic tool and as a treatment. Contradicting Kilbride, however, I argue that IVF-PGT provides neither diagnosis nor treatment under CMS’s definition. Thus, as long as we accept CMS’s definition of medically necessary care—which Kilbride does, explicitly—it follows that IVF-PGT does not count as medically necessary care. Still, there may be other reasons to conclude that IVF-Preimplantation genetic testing should be covered, and so, it would be a mistake to reject Kilbride’s conclusion altogether. The problem is simply that Kilbride’s argument—that the procedure should be covered because it is medically necessary per CMS’s definition—is not sound. I conclude by discussing a number of other genetic services that are not currently being covered despite the fact that (unlike IVF-PGT) they do seem to satisfy CMS’s definition of ‘medically necessary diagnosis or treatment’. These services, I argue, should be provided under CMS before we consider expanding coverage to include elective procedures such as IVF-PGT.


2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Stephen Denning

2018 ◽  
pp. 181-216 ◽  
Author(s):  
Laura G. Wilkinson ◽  
Dayton C. Bird ◽  
Matthew R. Tucker

2011 ◽  
Vol 49 (No. 4) ◽  
pp. 151-155 ◽  
Author(s):  
O. Tománková ◽  
P. Homolka

An in vitro method was used to determine ruminal degradability of starch (IVRDS) in a set of cereal grains. The set included 9 feed samples, including 2 samples of ground wheat, 2 samples of wheat treated with sodium hydroxide, ground barley, barley treated with sodium hydroxide, 2 samples of ground oats and ground maize. Ruminal degradability of starch was assayed by the feed fermentation for 2, 4, 6, 16 and 24 hours. A significant difference in starch degradability was found between treated and untreated ground samples after 2-hour fermentation (13.73 ± 3.12 vs. 32.77 ± 8.17; P < 0.001), 4-hour fermentation (33.44 ± 7.31 vs. 60.30 ± 16.71; P < 0.001) and 6-hour fermentation (42.63 ± 7.13 vs. 74.20 ± 6.38; P < 0.001). On the basis of the rate of ruminal degradability of starch the order of cereal grains was as follows (from the highest to the lowest value): ground oats, ground wheat, ground barley, ground maize, wheat and barley treated with sodium hydroxide.


1984 ◽  
Vol 106 (1) ◽  
pp. 117-123 ◽  
Author(s):  
Nobuki Kawashima ◽  
Kazunori Akai ◽  
Yukio Murasato ◽  
Susumu Sasaki

Sign in / Sign up

Export Citation Format

Share Document